Astrazeneca (AZN) Debt to Equity Ratio
Current and historical debt to equity ratio values for Astrazeneca (AZN) over the last 10 years.
|Medical||Large Cap Pharmaceutical||$73.315B||$23.002B|
|AstraZeneca PLC is one of the top five pharmaceutical companies in the world based on sales and is a therapeutic leader in cardiovascular, gastrointestinal, oncology, anesthesia including pain management, central nervous system (CNS) and respiratory products. They are engaged in the research, development, manufacture and marketing of ethical (prescription) pharmaceuticals and agricultural products, and the supply of healthcare services.|